These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27678206)

  • 21. Clinical and genetic data of Huntington disease in Moroccan patients.
    Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
    Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).
    Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I;
    Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrastriatal degeneration correlates with deficits in the motor domain subscales of the UHDRS.
    Galvez V; Ramírez-García G; Hernandez-Castillo CR; Bayliss L; Díaz R; Lopez-Titla MM; Campos-Romo A; Fernandez-Ruiz J
    J Neurol Sci; 2018 Feb; 385():22-29. PubMed ID: 29406908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
    Vuillaume I; Vermersch P; Destée A; Petit H; Sablonnière B
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):758-62. PubMed ID: 9647305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
    Apolinário TA; Paiva CL; Agostinho LA
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis and natural history of Huntington disease.
    Pagan F; Torres-Yaghi Y; Altshuler M
    Handb Clin Neurol; 2017; 144():63-67. PubMed ID: 28947126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset Huntington's disease with 40-42 CAG expansion.
    Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
    Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.
    Menéndez-González M; Clarimón J; Rosas-Allende I; Blázquez M; San Martín ES; García-Fernández C; Lleó A; Dols-Icardo O; Illán-Gala I; Morís G; Ribacoba R; Álvarez V; Martínez C
    Neurobiol Aging; 2019 Apr; 76():215.e9-215.e14. PubMed ID: 30583877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
    Vassos E; Panas M; Kladi A; Vassilopoulos D
    J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Genetic Aspects of Huntington's Disease in the Malian Population.
    Bocoum A; Coulibaly T; Ouologuem M; Cissé L; Diallo SH; Maiga BB; Dembélé K; Diallo S; Coulibaly SDP; Kané F; Coulibaly T; Coulibaly D; Taméga A; Yalcouyé A; Diarra S; Dembélé ME; Maiga AB; Cissé CAK; Traoré O; Fischbeck KH; Guinto CO; Maiga Y; Landouré G;
    J Huntingtons Dis; 2022; 11(2):195-201. PubMed ID: 35311712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.
    Witjes-Ané MN; Mertens B; van Vugt JP; Bachoud-Lévi AC; van Ommen GJ; Roos RA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):310-7. PubMed ID: 17827417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
    Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
    Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
    Lowe AJ; Sjödin S; Rodrigues FB; Byrne LM; Blennow K; Tortelli R; Zetterberg H; Wild EJ
    PLoS One; 2020; 15(8):e0233820. PubMed ID: 32804976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington's Disease.
    Kolenc M; Kobal J; Podnar S
    J Huntingtons Dis; 2017; 6(2):105-113. PubMed ID: 28482643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.